Issues impacting the hospital industry; Issues impacting hospital reimbursement; Issues related to workforce development and graduate medical education, H.R. 2389/S. 1302 - Resident Physician Shortage Reduction Act of 2023; Provisions of H.R.5378 - Lower Costs, More Transparency Act.
Issues related to workforce development and graduate medical education, H.R. 2389/S. 1302 - Resident Physician Shortage Reduction Act of 2023; Issues related to FEMA reimbursement; Issues impacting hospital reimbursement; Provisions of H.R.5378 - Lower Costs, More Transparency Act; Regulations related to oversight of laboratory developed tests.
Duration: June 15, 2016
to
present
General Issues: Medicare/Medicaid , Health Issues
Spending: about $2,290,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2016: U.S. Senate, House of Representatives, Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Andrew McKechnie Health Policy Advisor, Sen. Finance Committee; Legislative Assistant, Senator Norm Coleman; Legislative Assistant, Rep. Jim Ramstad; Bipartisan Medical Technology Caucus
Health Policy Advisor, Sen. Finance Committee;
Legislative Assistant, Senator Norm Coleman;
Legislative Assistant, Rep. Jim Ramstad;
Bipartisan Medical Technology Caucus
Emily Kirlin Director of Member Services, Senator John Cornyn;
Whip Liaison, Senator Jon Kyl;
Internal Communications Advisor, Senator Lamar Alexander
John Twomey Chief of Staff, HHS Office of the Asst. Sec. for Legislation (2019-2021); Policy Adviser, HHS (2017-2019); Special Asst., Office of the Secretary, HHS (2017); Staff Assistant, Rep. Tom Price (2015-2017); Intern, Rep. Doug Collins (2015)
Corey Malmgren Sen. Bill Nelson, Deputy Legislative Director & Health Counsel (2015-2018); Rep. Sandy Levin, Legislative Counsel (2013-2015), Legislative Correspondent, Staff Assistant (2008-2009); House Committee on Ways and Means, Legal Clerk/Intern (2010)
Lindsey Ledwin n/a
Sean Richardson n/a
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, Tiber Creek Group lobbied for The Ickes and Enright Group (on behalf of Greater New York Hospital Association) , earning $80,000. The report was filed on April 12.
Original Filing: 301548846.xml
Lobbying Issues
Issues impacting the hospital industry; Issues impacting hospital reimbursement; Issues related to workforce development and graduate medical education, H.R. 2389/S. 1302 - Resident Physician Shortage Reduction Act of 2023; Provisions of H.R.5378 - Lower Costs, More Transparency Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to workforce development and graduate medical education, H.R. 2389/S. 1302 - Resident Physician Shortage Reduction Act of 2023; Issues related to FEMA reimbursement; Issues impacting hospital reimbursement; Provisions of H.R.5378 - Lower Costs, More Transparency Act; Regulations related to oversight of laboratory developed tests.
Agencies Lobbied
U.S. Senate
4th Quarter, 2023
In Q4, Tiber Creek Group lobbied for The Ickes and Enright Group (on behalf of Greater New York Hospital Association) , earning $80,000. The report was filed on Jan. 12.
Original Filing: 301524012.xml
Lobbying Issues
Issues impacting the hospital industry; Issues impacting hospital reimbursement; Issues related to workforce development and graduate medical education, H.R. 2389/S. 1302 - Resident Physician Shortage Reduction Act of 2023; Issues impacting hospital reimbursement; H.R.5378 - Lower Costs, More Transparency Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Federal COVID response and issues impacting the hospital industry; Issues related to workforce development and graduate medical education, H.R. 2389/S. 1302 - Resident Physician Shortage Reduction Act of 2023; Issues related to FEMA reimbursement; Issues impacting hospital reimbursement; H.R.5378 - Lower Costs, More Transparency Act; S.2840 - Bipartisan Primary Care and Health Workforce Act; Regulations related to oversight of laboratory developed tests.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2023
In Q3, Tiber Creek Group lobbied for The Ickes and Enright Group (on behalf of Greater New York Hospital Association) , earning $80,000. The report was filed on Oct. 15, 2023.
Original Filing: 301500915.xml
Lobbying Issues
Issues impacting the hospital industry; Issues impacting hospital reimbursement; Issues related to workforce development and graduate medical education, H.R. 2389/S. 1302 - Resident Physician Shortage Reduction Act of 2023.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Federal COVID response and issues impacting the hospital industry; Issues related to workforce development and graduate medical education, H.R. 2389/S. 1302 - Resident Physician Shortage Reduction Act of 2023; Issues related to FEMA reimbursement; Issues impacting hospital reimbursement; H.R.5378 - Lower Costs, More Transparency Act; S.2840 - Bipartisan Primary Care and Health Workforce Act; Regulations related to oversight of laboratory developed tests.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2023
In Q2, Tiber Creek Group lobbied for The Ickes and Enright Group (on behalf of Greater New York Hospital Association) , earning $80,000. The report was filed on July 14, 2023.
Original Filing: 301476731.xml
Lobbying Issues
Issues impacting the hospital industry; Issues impacting hospital reimbursement; Issues related to workforce development and graduate medical education, H.R. 2389/S. 1302 - Resident Physician Shortage Reduction Act of 2023.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Federal COVID response and issues impacting the hospital industry; Issues related to workforce development and graduate medical education, H.R. 2389/S. 1302 - Resident Physician Shortage Reduction Act of 2023; Issues related to FEMA reimbursement; Issues impacting hospital reimbursement.
Agencies Lobbied
U.S. Senate
1st Quarter, 2023
In Q1, Tiber Creek Group lobbied for The Ickes and Enright Group (on behalf of Greater New York Hospital Association) , earning $80,000. The report was filed on April 16, 2023.
Original Filing: 301452317.xml
Lobbying Issues
Issues impacting the hospital industry; Issues related to workforce development and graduate medical education, H.R. 2389 - Resident Physician Shortage Reduction Act of 2023.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Federal COVID response and issues impacting the hospital industry; Issues related to workforce development and graduate medical education, H.R. 2389 - Resident Physician Shortage Reduction Act of 2023; Issues impacting the hospital industry; Issues related to FEMA reimbursement.
Agencies Lobbied
U.S. Senate
4th Quarter, 2022
In Q4, Tiber Creek Group lobbied for The Ickes and Enright Group (on behalf of Greater New York Hospital Association) , earning $80,000. The report was filed on Jan. 14, 2023.
Original Filing: 301427576.xml
Lobbying Issues
Federal COVID response and issues impacting the hospital industry; Issues related to workforce development and graduate medical education, S. 834/H.R. 2256 - Resident Physician Shortage Reduction Act of 2021; Issues related to hospital reimbursements, Consolidated Appropriations Act, 2023 (PL 117-328).
Agencies Lobbied
U.S. Senate
Lobbying Issues
Federal COVID response and issues impacting the hospital industry; Issues related to workforce development and graduate medical education, S. 834/H.R. 2256 - Resident Physician Shortage Reduction Act of 2021; Issues impacting the hospital industry; Issues related to FEMA reimbursement; Consolidated Appropriations Act, 2023 (PL 117-328).
Agencies Lobbied
U.S. Senate
3rd Quarter, 2022
In Q3, Tiber Creek Group lobbied for The Ickes and Enright Group (on behalf of Greater New York Hospital Association) , earning $80,000. The report was filed on Oct. 15, 2022.
Original Filing: 301404647.xml
Lobbying Issues
Federal COVID response and issues impacting the hospital industry; Issues related to workforce development and graduate medical education, S. 834/H.R. 2256 - Resident Physician Shortage Reduction Act of 2021; Issues related to hospital reimbursements; Issues related to H.R. 5376 - Build Back Better Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Federal COVID response and issues impacting the hospital industry; Issues related to workforce development and graduate medical education, S. 834/H.R. 2256 - Resident Physician Shortage Reduction Act of 2021; Workforce related issues in S. Con Res 14; Issues related to H.R. 5376 - Build Back Better Act; Issues impacting the hospital industry, Consolidated Appropriations Act, 2022 (PL 117-103); H.R. 7667/S. 4348 - Food and Drug Amendments of 2022, Issues related to FDA user fee agreements; Inflation Reduction Act of 2022 (PL 117-169); The legislative vehicle for the Continuing Resolution (PL 117-180).
Agencies Lobbied
U.S. Senate
2nd Quarter, 2022
In Q2, Tiber Creek Group lobbied for The Ickes and Enright Group (on behalf of Greater New York Hospital Association) , earning $80,000. The report was filed on July 15, 2022.
Original Filing: 301381463.xml
Lobbying Issues
Federal COVID response and issues impacting the hospital industry; Issues related to workforce development and graduate medical education, S. 834/H.R. 2256 - Resident Physician Shortage Reduction Act of 2021; Issues related to hospital reimbursements; Issues related to H.R. 5376 - Build Back Better Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Federal COVID response and issues impacting the hospital industry; Issues related to workforce development and graduate medical education, S. 834/H.R. 2256 - Resident Physician Shortage Reduction Act of 2021; Workforce related issues in S. Con Res 14; Issues related to H.R. 5376 - Build Back Better Act; Issues impacting the hospital industry, Consolidated Appropriations Act, 2022 (PL 117-103); Issues related to FDA user fee agreements (H.R.7667 and S.4348).
Agencies Lobbied
U.S. Senate
1st Quarter, 2022
In Q1, Tiber Creek Group lobbied for The Ickes and Enright Group (on behalf of Greater New York Hospital Association) , earning $80,000. The report was filed on April 15, 2022.
Original Filing: 301357261.xml
Lobbying Issues
Federal COVID response and issues impacting the hospital industry; Issues related to workforce development and graduate medical education, S. 834/H.R. 2256 - Resident Physician Shortage Reduction Act of 2021; Issues related to hospital reimbursements; Issues related to H.R. 5376 - Build Back Better Act; Issues related to S. 610 - Protecting Medicare and American Farmers from Sequester Cuts Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Federal COVID response and issues impacting the hospital industry; Issues related to workforce development and graduate medical education, S. 834/H.R. 2256 - Resident Physician Shortage Reduction Act of 2021; Workforce related issues in S. Con Res 14; Issues related to H.R. 5376 - Build Back Better Act; Issues impacting the hospital industry, Consolidated Appropriations Act, 2022 (PL 117-103).
Agencies Lobbied
U.S. Senate
4th Quarter, 2021
In Q4, Tiber Creek Group lobbied for The Ickes and Enright Group (on behalf of Greater New York Hospital Association) , earning $80,000. The report was filed on Jan. 15, 2022.
Original Filing: 301323325.xml
Lobbying Issues
Federal COVID response and issues impacting the hospital industry; Issues related to workforce development and graduate medical education, S. 834/H.R. 2256 - Resident Physician Shortage Reduction Act of 2021; Issues related to hospital reimbursements; Issues related to H.R. 5376 - Build Back Better Act; Issues related to S. 610 - Protecting Medicare and American Farmers from Sequester Cuts Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Federal COVID response and issues impacting the hospital industry; Issues related to workforce development and graduate medical education, S. 834/H.R. 2256 - Resident Physician Shortage Reduction Act of 2021; Workforce related issues in S. Con Res 14. Issues related to H.R. 5376 - Build Back Better Act.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2021
In Q3, Tiber Creek Group lobbied for The Ickes and Enright Group (on behalf of Greater New York Hospital Association) , earning $80,000. The report was filed on Oct. 16, 2021.
Original Filing: 301300499.xml
Lobbying Issues
Federal COVID response and issues impacting the hospital industry; Issues related to workforce development and graduate medical education; Issues related to hospital reimbursements.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Federal COVID response and issues impacting the hospital industry; Issues related to workforce development and graduate medical education; S. 834/H.R. 2256 - Resident Physician Shortage Reduction Act of 2021; Workforce related issues in S. Con Res 14.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2021
In Q2, Tiber Creek Group lobbied for The Ickes and Enright Group (on behalf of Greater New York Hospital Association) , earning $80,000. The report was filed on July 16, 2021.
Original Filing: 301277446.xml
Lobbying Issues
Federal COVID response and issues impacting the hospital industry; Issues related to workforce development and graduate medical education; Issues related to hospital reimbursements
Agencies Lobbied
U.S. Senate
Lobbying Issues
Federal COVID response and issues impacting the hospital industry; Issues related to workforce development and graduate medical education; S. 834 - Resident Physician Shortage Reduction Act of 2021; H.R.2256 - Resident Physician Shortage Reduction Act of 2021
Agencies Lobbied
U.S. Senate
1st Quarter, 2021
In Q1, Peck Madigan Jones lobbied for The Ickes and Enright Group (on behalf of Greater New York Hospital Association) , earning $80,000. The report was filed on April 17, 2021.
Original Filing: 301255382.xml
Lobbying Issues
Federal COVID response and issues impacting the hospital industry; Issues related to workforce development and graduate medical education; Issues related to hospital reimbursements, H.R. 1868 - Medicare Sequester
Agencies Lobbied
U.S. Senate
Lobbying Issues
Federal COVID response and issues impacting the hospital industry; Issues related to workforce development and graduate medical education; Issues related to Federal COVID response and issues impacting the hospital industry in PL 117-2 - American Rescue Plan Act of 2021; S. 834 - Resident Physician Shortage Reduction Act of 2021.
Agencies Lobbied
U.S. Senate
4th Quarter, 2020
In Q4, Peck Madigan Jones lobbied for The Ickes and Enright Group (on behalf of Greater New York Hospital Association) , earning $80,000. The report was filed on Jan. 19, 2021.
Original Filing: 301236651.xml
Lobbying Issues
Federal COVID response and issues impacting the hospital industry. Issues related to workforce development and graduate medical education. Issues related to H.R. 133 / PL 116-260 - FY2021 Omnibus and COVID Relief and Response Act.
Agencies Lobbied
U.S. Senate
Type of Issue
Medicare/Medicaid
3rd Quarter, 2020
In Q3, Peck Madigan Jones lobbied for The Ickes and Enright Group (on behalf of Greater New York Hospital Association) , earning $80,000. The report was filed on Oct. 20, 2020.
Original Filing: 301221226.xml
Lobbying Issues
Federal COVID response and issues impacting the hospital industry
Agencies Lobbied
U.S. Senate
Type of Issue
Medicare/Medicaid
2nd Quarter, 2020
In Q2, Peck Madigan Jones lobbied for The Ickes and Enright Group (on behalf of Greater New York Hospital Association) , earning $80,000. The report was filed on July 20, 2020.
Original Filing: 301198571.xml
Lobbying Issues
General Medicare and Medicaid issues. Federal COVID response, including Coronavirus Preparedness and Response Supplemental Appropriations Act (Public Law No. 116-123), Families First Coronavirus Response Act (Public Law No. 116-127), Coronavirus Aid, Relief, and Economic Security (CARES) Act (Public Law 116-136), and H.R. 6800 Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Federal COVID response, including Coronavirus Preparedness and Response Supplemental Appropriations Act (Public Law No. 116-123), Families First Coronavirus Response Act (Public Law No. 116-127), Coronavirus Aid, Relief, and Economic Security (CARES) Act (Public Law 116-136), and H.R. 6800 Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act
Agencies Lobbied
U.S. Senate
1st Quarter, 2020
In Q1, Peck Madigan Jones lobbied for The Ickes and Enright Group (on behalf of Greater New York Hospital Association) , earning $80,000. The report was filed on April 20, 2020.
Original Filing: 301177835.xml
Lobbying Issues
General Medicare and Medicaid issues, and funding for graduate medical education including the Opioid Workforce Act, H.R. 2439, and the Resident Physician Shortage Reduction Act of 2019, H.R. 1763/S. 348. Federal COVID response, including Coronavirus Preparedness and Response Supplemental Appropriations Act (Public Law No. 116-123), Families First Coronavirus Response Act (Public Law No. 116-127), Coronavirus Aid, Relief, and Economic Security (CARES) Act (Public Law 116-136)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to organ transplantation. Federal COVID response, including Coronavirus Preparedness and Response Supplemental Appropriations Act (Public Law No. 116-123), Families First Coronavirus Response Act (Public Law No. 116-127), Coronavirus Aid, Relief, and Economic Security (CARES) Act (Public Law 116-136)
Agencies Lobbied
U.S. Senate
4th Quarter, 2019
In Q4, Peck Madigan Jones lobbied for The Ickes and Enright Group (on behalf of Greater New York Hospital Association) , earning $80,000. The report was filed on Jan. 17, 2020.
Original Filing: 301110201.xml
Lobbying Issues
General Medicare and Medicaid issues, and funding for graduate medical education including the Opioid Workforce Act, H.R. 2439, and the Resident Physician Shortage Reduction Act of 2019, H.R. 1763/S. 348
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to organ transplantation.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2019
In Q3, Peck Madigan Jones lobbied for The Ickes and Enright Group (on behalf of Greater New York Hospital Association) , earning $80,000. The report was filed on Oct. 21, 2019.
Original Filing: 301077412.xml
Lobbying Issues
Issues related to implementation of PPACA (Pub. L. No. 111 -148) that impact hospital funding, general Medicare and Medicaid issues, and funding for graduate medical education including the Opioid Workforce Act, H.R. 2439, and the Resident Physician Shortage Reduction Act of 2019, H.R. 1763/S. 348
Agencies Lobbied
U.S. Senate
2nd Quarter, 2019
In Q2, Peck Madigan Jones lobbied for The Ickes and Enright Group (on behalf of Greater New York Hospital Association) , earning $80,000. The report was filed on July 22, 2019.
Original Filing: 301056805.xml
Lobbying Issues
Issues related to implementation of PPACA (Pub. L. No. 111 -148) that impact hospital funding, general Medicare and Medicaid issues, and funding for graduate medical education including the Opioid Workforce Act, H.R. 2439, and the Resident Physician Shortage Reduction Act of 2019, H.R. 1763/S. 348
Agencies Lobbied
U.S. Senate
1st Quarter, 2019
In Q1, Peck Madigan Jones lobbied for The Ickes and Enright Group (on behalf of Greater New York Hospital Association) , earning $80,000. The report was filed on April 22, 2019.
Original Filing: 301036042.xml
Lobbying Issues
Issues related to implementation of PPACA (Pub. L. No. 111 -148) that impact hospital funding, general Medicare and Medicaid issues, and funding for graduate medical education
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to organ transplantation
Agencies Lobbied
U.S. Senate
4th Quarter, 2018
In Q4, Peck Madigan Jones lobbied for The Ickes and Enright Group (on behalf of Greater New York Hospital Association) , earning $80,000. The report was filed on Jan. 18, 2019.
Original Filing: 301009015.xml
Lobbying Issues
Issues related to implementation of PPACA (PL: 111-148) and its impact on hospitals; Funding for graduate medical education.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to implementation of PPACA (PL: 111-148) and its impact on hospitals; Funding for graduate medical education. H.R. 2267/S. 1301, Resident Physician Shortage Reduction Act of 2017. Liver Allocation Fairness Act, H.R. 6517
Agencies Lobbied
U.S. Senate
3rd Quarter, 2018
In Q3, Peck Madigan Jones lobbied for The Ickes and Enright Group (on behalf of Greater New York Hospital Association) , earning $80,000. The report was filed on Oct. 22, 2018.
Original Filing: 300995831.xml
Lobbying Issues
Issues related to implementation of PPACA (PL: 111-148) and its impact on hospitals; Funding for graduate medical education.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to implementation of PPACA (PL: 111-148) and its impact on hospitals; Funding for graduate medical education. S. 2843/H.R. 5818, The Opioid Workforce Act and H.R. 2267/S. 1301, Resident Physician Shortage Reduction Act of 2017. Liver Allocation Fairness Act, H.R. 6517
Agencies Lobbied
U.S. Senate
2nd Quarter, 2018
In Q2, Peck Madigan Jones lobbied for The Ickes and Enright Group (on behalf of Greater New York Hospital Association) , earning $80,000. The report was filed on July 20, 2018.
Original Filing: 300974157.xml
Lobbying Issues
Issues related to implementation of PPACA (PL: 111-148) and its impact on hospitals; Funding for graduate medical education.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to implementation of PPACA (PL: 111-148) and its impact on hospitals; Funding for graduate medical education. S. 2843/H.R. 5818, The Opioid Workforce Act and H.R. 2267/S. 1301, Resident Physician Shortage Reduction Act of 2017.
Agencies Lobbied
U.S. Senate
1st Quarter, 2018
In Q1, Peck Madigan Jones lobbied for The Ickes and Enright Group (on behalf of Greater New York Hospital Association) , earning $80,000. The report was filed on April 20, 2018.
Original Filing: 300954522.xml
Lobbying Issues
Issues related to implementation of PPACA (PL: 111-148) and its impact on hospitals; Funding for graduate medical education. Disproportionate Share Hospital Funding.
Agencies Lobbied
U.S. Senate
Type of Issue
Medicare/Medicaid
4th Quarter, 2017
In Q4, Peck Madigan Jones lobbied for The Ickes and Enright Group (on behalf of Greater New York Hospital Association) , earning $80,000. The report was filed on Jan. 22, 2018.
Original Filing: 300937024.xml
Lobbying Issues
Issues related to implementation of PPACA (PL: 111-148) and its impact on hospitals; Issues related to the American Health Care Act and Better Care Reconciliation Act (HR 1628) and legislation proposed by Senators Graham and Cassidy; Funding for graduate medical education. Disproportionate Share Hospital Funding.
Agencies Lobbied
U.S. Senate
Type of Issue
Medicare/Medicaid
3rd Quarter, 2017
In Q3, Peck Madigan Jones lobbied for The Ickes and Enright Group (on behalf of Greater New York Hospital Association) , earning $40,000. The report was filed on Oct. 20, 2017.
Original Filing: 300911491.xml
Lobbying Issues
Issues related to implementation of PPACA (PL: 111-148) and its impact on hospitals; Issues related to the American Health Care Act and Better Care Reconciliation Act (HR 1628) and legislation proposed by Senators Graham and Cassidy; Funding for graduate medical education. Disproportionate Share Hospital Funding.
Agencies Lobbied
U.S. Senate
Type of Issue
Medicare/Medicaid
2nd Quarter, 2017
In Q2, Peck Madigan Jones lobbied for The Ickes and Enright Group (on behalf of Greater New York Hospital Association) , earning $40,000. The report was filed on July 20, 2017.
Original Filing: 300892176.xml
Lobbying Issues
Issues related to implementation of PPACA (PL: 111-148) and its impact on hospitals; Issues related to the American Health Care Act and Better Care Reconciliation Act (HR 1628); Funding for graduate medical education. Disproportionate Share Hospital Funding.
Agencies Lobbied
U.S. Senate
Type of Issue
Medicare/Medicaid
1st Quarter, 2017
In Q1, Peck Madigan Jones lobbied for The Ickes and Enright Group (on behalf of Greater New York Hospital Association) , earning $40,000. The report was filed on April 20, 2017.
Original Filing: 300872394.xml
Lobbying Issues
Issues related to implementation of PPACA (PL: 111-148) and its impact on hospitals; Issues related to the American Health Care Act (HR 1628); Funding for graduate medical education
Agencies Lobbied
U.S. Senate
Type of Issue
Medicare/Medicaid
4th Quarter, 2016
In Q4, Peck Madigan Jones lobbied for The Ickes and Enright Group (on behalf of Greater New York Hospital Association) , earning $40,000. The report was filed on Jan. 23, 2017.
Original Filing: 300854800.xml
Lobbying Issues
Issues related to hospital payment changes in the 21st Century Cures Act (Public Law No: 114-255).
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to organ transplantation.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2016
In Q3, Peck Madigan Jones lobbied for The Ickes and Enright Group (on behalf of Greater New York Hospital Association) , earning $40,000. The report was filed on Oct. 20, 2016.
Original Filing: 300834989.xml
Lobbying Issues
Issues related to hospital payment changes. Issues related to Medicaid disproportionate share payments.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to organ transplantation.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2016
In Q2, Peck Madigan Jones lobbied for The Ickes and Enright Group (on behalf of Greater New York Hospital Association) , earning $10,000. The report was filed on July 20, 2016.
Original Filing: 300817343.xml
Lobbying Issues
Issues related to hospital payment changes.
Agencies Lobbied
U.S. Senate
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...